A share price of Cg Oncology Inc [CGON] is currently trading at $30.21, up 0.70%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CGON shares have gain 8.01% over the last week, with a monthly amount glided 6.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, UBS started tracking the stock with Buy rating on October 24, 2024, and set its price target to $60. On September 23, 2024, RBC Capital Mkts initiated with a Outperform rating and assigned a price target of $66 on the stock. ROTH MKM started tracking the stock assigning a Buy rating and suggested a price target of $65 on August 28, 2024. BofA Securities initiated its recommendation with a Buy and recommended $65 as its price target on June 28, 2024. Morgan Stanley started tracking with a Overweight rating for this stock on February 20, 2024, and assigned it a price target of $55. In a note dated February 20, 2024, Goldman initiated an Neutral rating and provided a target price of $42 on this stock.
Cg Oncology Inc experienced fluctuations in its stock price throughout the past year between $25.77 and $50.23. Currently, Wall Street analysts expect the stock to reach $62.33 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $30.21 at the most recent close of the market. An investor can expect a potential return of 106.32% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -139.69%, Pretax Profit Margin comes in at -105.78%, and Net Profit Margin reading is -105.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.16 and Total Capital is -0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.55 points at the first support level, and at 28.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.54, and for the 2nd resistance point, it is at 30.87.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cg Oncology Inc [NASDAQ:CGON] is 35.32. Also, the Quick Ratio is 35.32, while the Cash Ratio stands at 2.78. Considering the valuation of this stock, the price to sales ratio is 3382.17, the price to book ratio is 3.80.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Jan 13 ’25 when 1000.0 shares were sold. Director, Song Hong Fang completed a deal on Dec 16 ’24 to sell 0.7 million shares. Meanwhile, Director POST LEONARD E sold 1000.0 shares on Dec 16 ’24.
